During the last session, Opko Health Inc (NASDAQ:OPK)’s traded shares were 2.49 million, with the beta value of the company hitting 1.64. The 52-week high for the OPK share is $1.90, that puts it down -15.15 from that peak though still a striking 48.48% gain since the share price plummeted to a 52-week low of $0.85. The company’s market capitalization is $1.15B, and the average intraday trading volume over the past 10 days was 2.82 million shares, and the average trade volume was 3.39 million shares over the past three months.
Opko Health Inc (OPK) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 1.00. OPK has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 4 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.09.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Opko Health Inc (NASDAQ:OPK) trade information
The stock’s 5-day price performance is 1.85%, and it has moved by 15.38% in 30 days. Based on these gigs, the overall price performance for the year is -4.62%. The short interest in Opko Health Inc (NASDAQ:OPK) is 90.68 million shares and it means that shorts have 25.48 day(s) to cover.
The consensus price target of analysts on Wall Street is $3.5, which implies an increase of 52.86% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3 and $4 respectively. As a result, OPK is trading at a discount of -142.42% off the target high and -81.82% off the low.
Opko Health Inc (OPK) estimates and forecasts
Statistics show that Opko Health Inc has underperformed its competitors in share price, compared to the industry in which it operates. Opko Health Inc (OPK) shares have gone up 67.43% during the last six months, with a year-to-date growth rate less than the industry average at -20.00% against 12.50. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 18.20% this quarter and then jump 11.10% in the quarter after that. In the rating firms’ projections, revenue will decrease -18.30% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 181.52M as predicted by 6 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to 167.82M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 178.6M and 181.9M respectively. In this case, analysts expect current quarter sales to grow by 1.60% and then drop by -7.70% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 1.56%. While earnings are projected to return -25.60% in 2024, the next five years will return 12.00% per annum.
OPK Dividends
Opko Health Inc is due to release its next quarterly earnings in September. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Opko Health Inc (NASDAQ:OPK)’s Major holders
Opko Health Inc insiders own 52.78% of total outstanding shares while institutional holders control 27.11%, with the float percentage being 57.41%. RUBRIC CAPITAL MANAGEMENT LP is the largest shareholder of the company, while 297.0 institutions own stock in it. As of 2024-06-30, the company held over 44.42 million shares (or 6.2843% of all shares), a total value of $55.53 million in shares.
The next largest institutional holding, with 29.25 million shares, is of BLACKROCK INC.’s that is approximately 4.1373% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $36.56 million.
